Fingerprint
Dive into the research topics of 'Liraglutide reduces cardiovascular events and mortality in type 2 diabetes mellitus independently of baseline low-density lipoprotein cholesterol levels and statin use results from the LEADER trial'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically